Single dose of empagliflozin increases in vivo cardiac energy status in diabetic db/db mice

Cardiovasc Res. 2018 Dec 1;114(14):1843-1844. doi: 10.1093/cvr/cvy246.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Benzhydryl Compounds / administration & dosage*
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Diabetes Mellitus / diagnostic imaging
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / genetics
  • Diabetes Mellitus / metabolism
  • Disease Models, Animal
  • Energy Metabolism / drug effects*
  • Glucosides / administration & dosage*
  • Ketones / blood
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Male
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Phosphocreatine / analogs & derivatives
  • Phosphocreatine / metabolism
  • Sodium-Glucose Transporter 2 Inhibitors / administration & dosage*
  • Ventricular Function / drug effects

Substances

  • Benzhydryl Compounds
  • Blood Glucose
  • Glucosides
  • Ketones
  • Sodium-Glucose Transporter 2 Inhibitors
  • Phosphocreatine
  • phosphocreatinine
  • Adenosine Triphosphate
  • empagliflozin